Traxion Sab De Cv Ord Shs GRPOF

RE:RE:RE:RE:RE:RE:RE:RE:Science

[FormerSupporter]

I agree with the GMU discussion and the potential benefit to Tetra. The negative that cannot be ignored stems from the failure of Tetra to provide clear and accurate communication and updates to its shareholders and not keep everything clocked in so much mystery and secrets that the entire market discounts what is being issued by Tetra. If Guy can simply tell us what has been achieved and what real time lines exist then I believe your analysis and comments will stand and the stock will move. I'm not bashing Tetra or Guy but simply pointing out what he needs to do to get real support in the market and move the stock. That and their desperate need to raise money to complete trials and move the needle towards drug development significantly. Like I said before, I believe in the products and science. The corporate culture from the board and executives i believe will down kill this company if they don't do a real financing and complete trials. I recall in 2019 Guy and Tetra took a lot of heat as he said in a tweet and article that 50 million was needed for drug development. It was later stated to be a general comment and the share price stabilized. The truth was that is what Tetra needs in the bank today in order to achieve real milestones in drug development. That can be done on an equity raise, royalty based financing or strategic partnership. The stumbling blocks on the last two are the early stage programs are not gathering interest. The simply conclusion is to raise the money and advance an asset into a phase 3. I'm not walking away from Tetra just yet but I would urge Guy to finance the company properly first. Tetra has a new "hot shot" CFO and he needs to fund all these initiatives. Tetra has a regular cash burn of about 1.5 million per month in G&A. That is 18 million needed in 2021 to keep the lights on and progress. Plus anywhere from 4 to 6 million per trial that they need to run. If they are committed to QIXLEEF and ARDS with CAUMZ shelved, then that is around another 8 to 12 million to do both. Tetra needs to get 26 to 30 million minimum to make this work. Likely in Q1 2021 to ensure no delays. That will leave little wiggle room. In 2020 they raised 27 million between the Echelon bought deal of 17 million in February/March and 9 million in May from Raymond James and Canaccord. I'm just looking at the public information and scratching my head.